000 | 01936 a2200493 4500 | ||
---|---|---|---|
005 | 20250516114814.0 | ||
264 | 0 | _c20130319 | |
008 | 201303s 0 0 eng d | ||
022 | _a1365-2141 | ||
024 | 7 |
_a10.1111/bjh.12090 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBraza, Mounia S | |
245 | 0 | 0 |
_aAnti-tumour immunotherapy with Vγ9Vδ2 T lymphocytes: from the bench to the bedside. _h[electronic resource] |
260 |
_bBritish journal of haematology _cJan 2013 |
||
300 |
_a123-32 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAdaptive Immunity |
650 | 0 | 4 |
_aAdjuvants, Immunologic _xpharmacology |
650 | 0 | 4 |
_aAntigens, Neoplasm _ximmunology |
650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _ximmunology |
650 | 0 | 4 |
_aCells, Cultured _xdrug effects |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 |
_aDendritic Cells _ximmunology |
650 | 0 | 4 |
_aDiphosphonates _xpharmacology |
650 | 0 | 4 | _aGene Rearrangement, delta-Chain T-Cell Antigen Receptor |
650 | 0 | 4 | _aGene Rearrangement, gamma-Chain T-Cell Antigen Receptor |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunity, Innate |
650 | 0 | 4 |
_aImmunologic Surveillance _ximmunology |
650 | 0 | 4 | _aImmunotherapy, Adoptive |
650 | 0 | 4 |
_aKiller Cells, Natural _ximmunology |
650 | 0 | 4 |
_aMesenchymal Stem Cells _ximmunology |
650 | 0 | 4 |
_aNeoplasms _ximmunology |
650 | 0 | 4 |
_aReceptors, Antigen, T-Cell, alpha-beta _xanalysis |
650 | 0 | 4 |
_aReceptors, Antigen, T-Cell, gamma-delta _xanalysis |
650 | 0 | 4 |
_aT-Lymphocyte Subsets _xchemistry |
650 | 0 | 4 |
_aT-Lymphocytes, Cytotoxic _xchemistry |
650 | 0 | 4 |
_aT-Lymphocytes, Regulatory _ximmunology |
650 | 0 | 4 | _aTranslational Research, Biomedical |
650 | 0 | 4 |
_aTumor Escape _ximmunology |
700 | 1 | _aKlein, Bernard | |
773 | 0 |
_tBritish journal of haematology _gvol. 160 _gno. 2 _gp. 123-32 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/bjh.12090 _zAvailable from publisher's website |
999 |
_c22180695 _d22180695 |